托西利祖马布用于肺移植中抗体介导的排斥治疗
Spenser E January1, Keith A Fester1, Laura P Halverson2
1Department of Pharmacy, Barnes-Jewish Hospital , Saint Louis, Missouri.
概括
托西利祖马布 (TCZ) 在肺移植患者中有效治疗抗体介导排斥 (AMR). 这种IL-6抑制剂降低了捐赠者特异性抗体 (DSA) 和移植失败,为未来的临床试验显示了希望.
科学领域:
- 免疫学 免疫学 免疫学
- 移植医学 移植医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗体介导排斥 (AMR) 是肺移植的一个重大挑战.
- 捐赠者特异性抗体 (DSA) 导致AMR和移植功能障碍.
- 互白素-6 (IL-6) 在AMR病变发生过程中发挥作用.
研究的目的:
- 评估IL-6抑制剂托西利祖马布 (TCZ) 在接受肺移植患者的AMR治疗中的疗效.
- 为了比较使用TCZ治疗的AMR治疗结果与没有TCZ的标准护理.
主要方法:
- 追溯的病例控制研究.
- 与9名接受肺移植的患者进行 AMR 治疗与TCZ,与18名没有TCZ治疗的患者进行了比较.
- 评估DSA水平,移植失败和不良事件.
主要成果:
- 治疗TCZ导致更大的DSA清除和新的DSA的发病率较低.
- 接受TCZ治疗的患者的移植失败率较低.
- 在两组之间观察到类似的输液反应,高氨酸酶和感染率.
结论:
- 托西利祖马布显示出作为治疗肺部AMR的潜力.
- 初步证据支持通过随机对照试验进一步调查IL-6抑制在AMR管理中的作用.
更多相关视频
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
178
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
178
01:19Antiasthma Drugs: Leukotriene Modifiers
379
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
379
01:26Kidney Transplant II: Surgical Procedure
37
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
37
01:27Tumor Immunotherapy
577
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
577
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
205
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
205
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
361
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
361